HeartFlow, a California-based healthcare technology company focused on cardiac care, has shared its support of new guidelines from the American College of Cardiology and American Heart Association that detail the evaluation and diagnosis of chest pain.
HeartFlow noted that the new guidelines recognized its AI-powered HeartFlow FFRCT Analysis solution as a “reasonable,” “effective” treatment option for diagnosing coronary artery disease (CAD). The document also emphasized the importance of coronary CT angiography (CTA) as a first-line test for valuating CAD patients, an update sure to get more clinicians interested in that modality than ever before.
“Since inception, HeartFlow has been committed to producing comprehensive clinical evidence to substantiate the diagnostic accuracy, safety, efficacy, cost-effectiveness, and utility of our technology and we are delighted to see the clinical recommendations for its use through these updated guidelines,” John H. Stevens, MD, president, CEO and co-founder of HeartFlow, said in a prepared statement. “We anticipate the guidelines will translate to stronger adoption of our precision heart care technology and look forward to supporting an expanded patient and physician population that can benefit from the advanced diagnostic capability it provides.”
“This evolution of the guidelines, and its impact to patients and clinicians, marks a watershed moment in CAD diagnosis and treatment,” Campbell Rogers, MD, chief medical officer of HeartFlow, said in the same statement. “The recommendations crystallize coronary CTA as the ascendent front-line test to diagnose CAD accurately and indicate the critical role our HeartFlow Analysis should play in making patient-specific decisions about when to go to the catheterization lab and what revascularization treatment strategies to employ.”
Related Cardiac CT Content:
VIDEO: Cardiac CT now recommended as a front line chest pain assessment tool — Interview with Leslee Shaw, PhD
VIDEO: Office-based cardiac CT and FFR-CT offer a new business model
‘A watershed moment’: HeartFlow praises new chest pain guidelines
Imaging group says new guidelines for chest pain contain some ‘troubling recommendations’
American Society of Nuclear Cardiology says AHA/ACC chest pain guidelines miss the mark
Expert panel recommends coronary CTA as first choice when evaluating for stable CAD
Find more ACC conference news and video
Michael has more than 16 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.